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Electrospray ionization mass spectrometry (ESI-MS) is an attractive analytical tool for
high-throughput screening because of its rapid scan time and ability to detect compounds
without need for labels. Impediments to the use of ESI-MS for screening have been the
relatively large sample consumed and slow sample introduction rates associated with
commonly used flow injection analysis. We have previously shown that by segmenting
nanoliter plugs of sample with air, an array of discrete samples can be delivered to a
platinum-coated emitter tip for ESI-MS analysis with throughput as high as 0.8 Hz and
carry-over between samples less than 0.1%. This method was applied to screening for
inhibitors of acetylcholinesterase as a demonstration of the potential of segmented flow
ESI-MS for such applications. Each enzyme assay consumed 10 nL of sample. At 1 L/min
infusion rate, 102 samples were analyzed, corresponding to a 0.65 Hz sample analysis rate.
Linear quantification of choline was achieved from 200 M to 10 mM using this method and
Z= values were over 0.8 for the assay. Detailed pharmacologic dose-response curves of selected
inhibitors were also measured in high-throughput fashion to validate the method. (J Am Soc
Mass Spectrom 2010, 21, 1107–1113) © 2010 Published by Elsevier Inc. on behalf of American
Society for Mass SpectrometryDrug discovery often requires identification oflead compounds from combinatorial libraries con-taining millions of candidates. High-throughput
screening (HTS) is necessary for such large scale sample
handling and measurement [1]. In vitro biochemical
assay in multiwell plates with optical detection has
been the primary format for HTS [2–4]. A drawback of
optical detection is that usually either labels or indicator
reactions must be incorporated into the assay to gener-
ate detectable signal. This requirement results in several
problems, including increased difficulty of assay devel-
opment, increased cost because of added or complex
reagents, and greater potential for inaccurate results if
test compounds affect the label or indicator reaction
rather than the test reaction. High-throughput assays
that can be performed without labels or indicator reac-
tions are therefore of great interest [5].
A potentially powerful label-free detection system is
electrospray ionization mass spectrometry (ESI-MS).
Indeed, a variety of ESI-MS assays for enzymes and
noncovalent biomolecule binding have been developed
and explored for screening applications [5–7]. The
throughput achievable by ESI-MS is limited by the need
to interface the mass spectrometer to multiwell plates
and perform individual injections for each assay (this
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compound at a time; for certain assays, MS can analyze
a mixture of test compounds at one time [8, 9]). Cur-
rently, individual samples are most often introduced to
a mass spectrometer by flow injection, i.e., loading
sample into an HPLC-style injection valve and then
pumping it through the ESI emitter. It is a significant
challenge to engineer a rapid injection system that uses
small volumes, has low carry-over between injections,
uses low flow rates, and is reliable. A rapid system that
requires just 4 to 5 s per analysis and consumes 1 to 5 L
of sample has been commercialized [10]; however, more
common systems are considerably slower and require a
few minutes per sample. For HTS, it is desirable to
lower the volume of sample consumed, to reduce
reagent costs, and further increase throughput. A po-
tentially interesting alternative to flow injection is the
use of microfabricated nanospray emitter arrays that can
be interfaced to multiwell plates using a liquid handling
robot (e.g., NanoMate by Advion BioSciences Inc., Ithaca,
NY, USA). This system uses a few microliters to load
nanospray tips and a cycle time of 40 s/sample [11].
In this work, we eliminated the need for flow injec-
tion by utilizing segmented flow analysis for high-
throughput ESI-MS. Segmented flow has long been a
popular method for high-throughput analysis in clinical
settings [12]. In the classic scheme, individual samples
are segmented by air in a tube, reagents added for
colorimetric assay, and the samples passed through an
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resurgence of interest in segmented flow with the
advent of sophisticated microfluidics that allow minia-
turization (femtoliter to nanoliter samples) and new
methods for manipulating sample plugs and droplets
[14–16]. We have recently demonstrated the feasibility
of directly pumping segmented flow through an ESI
emitter tip to obtain mass spectrometric analysis of
discrete sample plugs at high-throughput (0.8 Hz
analysis rate) with low carry-over [17]. Other groups
have also reported ESI-MS of droplet samples [18,
19]. The success of these methods suggests that they
may be applicable to rapid, label-free screening of
assay mixtures.
As a test system, we demonstrate screening for
inhibitors of acetylcholinesterase (AchE). AchE cata-
lyzes conversion of acetylcholine (Ach) to choline and is
the primary way of terminating Ach signaling at syn-
apses. Inhibition of AchE is a possible treatment for
Alzheimer’s disease (AD) and related dementia [20, 21].
While a handful of AchE inhibitors have been approved
for AD treatment, searching for compounds with im-
proved pharmacologic and toxicologic properties re-
mains an active pursuit [22].
Because the AchE reaction does not generate compo-
nents that are easily detected optically, screening has
required coupling the enzyme with indicator reactions
[23–25]. It has been demonstrated that AchE assays can
be performed using flow-injection ESI-MS [26] and
HPLC-MS [27] to directly detect substrate and/or prod-
uct of the reaction. Throughput of 0.2 Hz with 1 to 5 L
of sample consumption was possible when using an
automated sampling and injection system [27]. In this
work, we demonstrate that with direct ESI-MS analysis
of segmented assay mixtures, we can generate a through-
put of 0.65 Hz for AchE inhibitor screening while consum-
ing 10 nL of sample. Excellent reproducibility indicated by
Z= values above 0.8 was also obtained.
Experimental
Chemicals and Reagents
Water and methanol were purchased from Burdick and
Jackson (Muskegon, MI, USA). Acetic acid was pur-
chased from Fisher Scientific (Pittsburgh, PA, USA). All
other chemicals were obtained from Sigma (St. Louis,
MO, USA).
AchE activity measurement. Assay conditions were
modified from a previously reported method [28]. Ten
mM NH4HCO3 was used as reaction buffer for all AchE
experiments. AchE (from Electrophorus electricus, type
VI-S) was prepared daily from lyophilized powder at 90
g/mL solution; 2 L solution of drug to be tested was
mixed with 20 L AchE solution and incubated on ice
for 30 min before being brought to room-temperature;
20 L 200 mM acetylcholine iodide solution was then
added to above AchE solution to start hydrolysis. After20 min incubation, 180 L of an ice-cold mixture
containing 1 mM chlormequat, 60% (vol/vol) methanol,
and 1.5% (vol/vol) acetic acid was rapidly mixed with
20 L of the enzyme mixture to terminate the reaction;
30 L of each final quenched reaction mixtures were
pipetted into a 384-well plate (Corning, Fisher Scien-
tific, Pittsburg, PA, USA) for loading into a sample tube
for analysis.
Sample plug generation. Air-segmented sample plugs
were generated using the system illustrated in Figure 1,
similar to that recently described [17]. A Teflon tube of
75 m i.d. and 360 m o.d. (IDEX Health and Science,
Oak Harbor, WA, USA) was used for sampling and
storing sample plugs. One end of this tubing was
connected to a 100 L syringe (Hamilton; Fisher Scien-
tific, Pittsburg, PA, USA) using a 250 m bore PEEK
union (Valco Instruments, Houston, TX, USA). The
syringe and Teflon tubing were initially filled with
Fluorinert FC-40 (Sigma). The syringe was mounted on
a PHD 200 programmable syringe pump (Harvard
Apparatus, Holliston, MA, USA). To fill the tube with
air-segmented samples, a computer-controlled xyz-
micropositioner (built in-house from XSlide assemblies;
Velmex Inc., Bloomfield, NY, USA) was used to move
the inlet of the Teflon tubing from sample-to-sample on
the multiwell plate while the pump was operated at a
fixed aspiration rate. By using an aspiration rate of 200
nL/min, 10 nL sample plugs and 4 mm long air plugs
were produced. Using this procedure, a tube could be
filled with 100 samples in 10 min. The relative stan-
dard deviation of sample plug size was 25% due to the
compressibility of air affecting the sampling rate with
increasing amount of air aspired into the tube.
Figure 1. Diagram of system for generating air-segmented sam-
ple plugs from a multiwell plate. Cartridges of sample plugs were
prepared by dipping the tip of a 75 m i.d. Teflon tubing prefilled
with Fluorinert FC-40 into sample solution stored in a multiwell
plate, aspirating a desired volume, retrieving the tube, aspirating
a desired volume of air, and moving to the next well until all
samples were loaded. Movement of the tubing was controlled
with an automated micropositioner and sample flow was con-
trolled with a syringe pump connected to the opposite end of the
tubing.
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tion, the inlet end of the Teflon tubing was connected to
a Pt-coated fused-silica electrospray emitter (FS 360-50-
8-CE; New Objective, Woburn, MA, USA), which was
50 m i.d. and pulled to 8 m i.d. at the tip, using a
360 i.d. Teflon connector. The emitter was mounted in a
nanospray source (PV-550; New Objective). A syringe
pump operated at 1.0 L/min was used to drive sample
plugs through the emitter poised at 1.7 kV for ESI-MS
analysis. The MS used was a LTQ XL linear ion trap MS
(Thermo Fisher Scientific, Waltham, MA, USA) oper-
ated in single-stage, full-scan mode with following
settings: automatic gain control (AGC) on, negative
mode, 50–300 m/z scan range, and micro scan number
1. Scan time was 0.1 s. Reconstructed ion current
traces (RIC) of choline (m/z 104) and chlormequat (m/z
122) were extracted from total ion current (TIC). Peak
marking and analysis were performed automatically by
Qual Browser. For determining inhibitor IC50 values,
GraphPad Prism 3.0 (GraphPad Software, San Diego,
CA, USA) was used for the curve fitting.
Results and Discussion
AchE Assay
Initial experiments were directed at determining AchE
assay conditions that would be compatible with ESI-
MS. Incubating acetylcholine with AchE in 10 mM
NH4HCO3 buffer for 20 min at room temperature
followed by quenching of the reaction by addition of a
methanol and acetic acid mixture was found to be
suitable. With this incubation time,10% of the original
acetylcholine was consumed, thus ensuring linear hy-
drolysis rates. The quenching solvent was found to
completely stop the enzymatic reaction and be compat-
ible with MS. NH4HCO3 provided adequate buffering
while being compatible with ESI and providing low ion
suppression. To improve quantification, chlormequat
was included in the quenching solution to act as an
internal standard [28]. Typical MS spectra illustrating
detection of substrate (acetylcholine), product (choline),
and internal standard are shown in Figure 2. Under the
electrospray conditions used, the spectra are free from
interfering peaks from the Fluorinert FC-40 used for
coating the Teflon tubing. Inhibitors added to the assay
reduced the choline signal as shown by Figure 2.
Segmented Flow ESI-MS Analysis for
Rapid Screening
To demonstrate rapid screening of AchE inhibitors, a
set of 32 compounds, including four known AchE
inhibitors and 28 randomly picked compounds, were
tested at 100 M each in the AchE assay mixtures. This
concentration was chosen because preliminary experi-
ments suggested that it allowed weaker inhibitors, such
as malathion, to be detected. For screening, each com-
pound was tested in triplicate, resulting in a total of 102samples (96 assay samples, plus 3 blanks with no
enzyme added, and 3 controls with no test compound
added). These samples were loaded into a Teflon tube
as a linear array using the procedure described in the
Experimental section. Throughput of analysis is deter-
mined by sample plug volume and flow rate into the
ESI source so that small sample volumes and high flow
rates generate higher throughput. For this work, 10 nL
sample plugs with 17 nL air gaps (or 4 mm spacing in a
150 m i.d. tubing) were chosen as a small-volume that
was convenient to produce. Samples were pumped
through the emitter at 1 L/min, which was the highest
flow rate that did not cause the samples to merge in the
emitter tip because of compression of the air segment.
These conditions allowed the 102 samples to be
analyzed in 2.6 min, corresponding to an analysis rate
of 0.65 Hz, as illustrated by ion current traces for the
analysis shown in Figure 3a. Each sample is detected as
a current burst followed by a period of zero current
corresponding to the air segment passing through the
emitter. As shown, the current rapidly stabilizes for
each sample and remains steady as the sample is passed
through the emitter. The presence of inhibitors is easily
visualized by the reduced choline signal relative to
internal standard signal in these traces. The inconse-
quential carry-over between samples is illustrated by
the immediate step change in signal between samples of
different choline concentrations.
The analysis rate of the segmented flow method
compares favorably with previously reported flow in-
jection AchE assays [26, 27, 29]. The speed of flow
injection methods was limited by the need to inject
individual samples or additional separation steps when
assay buffer was not directly compatible with ESI-MS. It
also seems likely to be able to further increase the
analysis rate of the plug samples. Higher flow rates
during analysis may be possible by using fluorocarbon
oil to segment samples to avoid the effect of air com-
pressibility. In preliminary studies with this approach,
we have improved analysis rate to 2.3 Hz. Also,
Figure 2. ESI mass spectra of quenched AchE assay mixtures
after incubating 100 mM acetylcholine, chlormequat (internal
standard or I.S.), and 45 g/mL AchE with (a) or without (b) 100
M the AchE inhibitor neostigmine at room temperature for 20
min. AchE inhibition is detected by decrease of choline signal
relative to control without inhibitor.generating lower volume samples by using smaller i.d.
as error bar.
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tioner that can move faster from well-to-well (relatively
slow response time of the positioners used here pre-
vented shorter aspiration times that would generate
smaller samples) would be able to decrease the time
required to analyze each sample. Ultimately, the anal-
ysis rate could become limited by the scan time of the
mass spectrometer used. For example, if plugs are
analyzed at 2 Hz and 10 mass spectra are acquired per
sample, a scan rate of 20 Hz is required, comparable to
many time-of-flight mass analyzers.
Overall Throughput
Although the rate of analysis was higher than previ-
ously reported ESI methods, the overall throughput
must be considered. For example, the above compari-
son neglects the time required to load sample plugs into
the tube for segmented flow analysis. In this proof of
concept study, overall throughput was actually limited
by sample loading because a single tube was loaded at
a rate that required 6 s per sample; however, it would
be a simple matter for a true HTS to load multiple tubes
in parallel using either multiple syringe pumps or a
single syringe pump with multiple barrels. Therefore,
sample loading is not expected to have a significant
effect on overall throughput of the segmented flow
method. A more complicated, but intriguing, possibility
to improve throughput would be to perform the entire
assay in plugs. Several tools for manipulating plugs
have been published, including mixing with streams,
reagent addition, and splitting [14, 30, 31]. Thus, it is
possible to envision a system in which a chemical
library is stored as a series of plugs that are then tested
and assayed by MS and by-passing the transfer from
multiwell plate to tubing. Such an approach would also
further decrease reagent usage.
Another issue that can be expected to impact overall
throughput is sample preparation. The segmented flow
assay was designed to be directly compatible with ESI
and therefore did not require solid-phase extraction to
remove salts or concentrate sample. It may not always
be possible to design assays that allow direct injection
into an ESI source. Current flow injection systems can
utilize in-line solid-phase extraction at high flow rates
so their throughput is minimally impacted by this
necessity [26]. Therefore, for the segmented flow ap-
proach to be as versatile as the flow injection approach
for HTS, it is necessary to develop systems that allow
compatible solid-phase extraction or similar sample
preparation steps that are high-throughput. One prom-
ising approach is parallel solid-phase extraction based
on multiple fibers [32].
Quantification
To quantify choline production in the enzyme reaction,
four different measurements were evaluated as shownFigure 3. Screening of AchE inhibitors by segmented flow-ESI-
MS. (a) RIC trace for choline (top) and chlormequat (bottom) of
102 AchE enzyme assay sample plugs analyzed by ESI-MS in
2.6 min. The series of samples tested 32 compounds in triplicate
for AchE inhibition plus two control samples, also in triplicate.
Compounds tested were, from left to right, control 1 (no drug
added); malathion, neostigmine, eserine, edrophonium, isopro-
terenol, yohimbine, UK14,304, DMSO, serine, adenosine, thyro-
nine, GABA, phenylalanine, alanine, proline, arginine, cyst-
eine, lysine, tyrosine, glycine, arginine, glutamine, methionine,
leucine, tryptophan, isoleucine, histidine, glutamic acid, aspar-
tic acid, taurine, dopamine, valine, control 2 (no enzyme
added). Inset shows signal for two inhibitors (edrophonium
and isoproterenol) and one inactive compound. (b) Quantifica-
tion of choline formed in each sample determined by subtract-
ing background formation of choline and comparing choline
signal (ratioed to internal standard) to calibration curve. Bars
show mean concentration from triplicate samples with 1 SDin Figure 4a. Absolute choline peak area had the most
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sample plugs had 25% variability. Peak heights were
less variable but could sometimes be affected by fluc-
tuation in electrospray stability. Choline peak area and
height relative to the internal standard had low vari-
ability, and both proved to be equally acceptable for
quantification.
Charge competition between choline and internal
standard chlormequat during electrospray and its effect
on quantification was also evaluated. Choline signal
intensity was measured from 200 M to 10 mM with a
fixed chlormequat concentration. This concentration
range was tested based on the amount of choline
formed during the enzyme assay. (Our previous work
has suggested that lower concentrations can be used for
assays that require it as the segmented flow electros-
pray method has high sensitivity [17].) As shown in
Figure 4b, choline signal increased with its concentra-
tion nonlinearly while chlormequat signal decreased
with increasing choline concentration. By using choline
signal relative to the internal standard, a linear calibra-
tion curve could be obtained, demonstrating that the
use of internal standard also helped to correct for
charge competition during ESI at different choline con-
centrations. In principle, an isotope-labeled internal
standard could be also used to correct for ionization
suppression if necessary.
Figure 3b summarizes quantification of the assay
Figure 4. Quantification of AchE hydrolysis. (a) Comparison of
relative standard deviation for different methods of quantifying
choline signal from RIC traces: peak height is the highest choline
ion intensity of all the scans over a sample plug; relative height is
the ratio of peak height of choline to that of chlormequat; peak
area is the area under all the MS scans of a sample plug; relative
area is ratio of the peak area of choline to that of chlormequat.
Error bars are 1 standard deviation (n  7). The average RSDs
were 5.9%, 28.5%, 1.9%, and 1.5% for calculation based on peak
height, peak area, relative height, and relative area respectively;
(b) calibration curve for choline. Solutions containing 0.9 mM
chlormequat and various concentrations of choline (200 M to 10
mM) were infused for ESI-MS analysis. Choline peak intensity
increased with its concentration nonlinearly while chlormequat
(I.S.) peak intensity decreased with higher choline concentration
(normalized peak intensities were used for both choline and
chlormequat). Using ratio of the two peak heights (relative peak
height) corrected the effect caused by charge competition during
ESI so that the ratio increased linearly with choline concentration.
The calibration curve based on relative peak height had slope of
0.11 mM1, y-intercept of 0.034, and r2 of 0.999.screen shown in Figure 3a using peak area ratio forcholine and internal standard. Four of the known AchE
inhibitors showed reduced choline production as ex-
pected. Interestingly, isoproterenol and DMSO also
showed some inhibition at this concentration. DMSO
increased signal of both choline and chlormequat; how-
ever, quantification was not affected since relative sig-
nal intensities were used. This result indicates that the
assay should be resistant to compounds that have
generalized effects on the ESI-MS process.
The reproducibility of the assay can be evaluated
using the Z=-factor [33]. Z=-factor is defined as Z′ 
1.0  3.0  sneg  spos ⁄R where sneg is the standard
deviation of the response of a negative control (no
inhibitor) and spos in the standard deviation of the
response of a positive control (with inhibitor) and R is
the difference in signal between the mean of positive
and negative controls. Z= over 0.5 is generally con-
sidered necessary for HTS. In our experiments, Z=
values for neostigmine, eserine, malathion and edro-
phonium were 0.84, 0.83, 0.87 and 0.85 respectively.
High Z= values were the direct result of excellent
reproducibility.
AchE Inhibitor Characterization
Another use of the assay is for rapid determination of
dose-response relationships for known inhibitors as
illustrated for neostigmine, eserine, malathion, and
edrophonium in Figure 5. For this experiment, 10 dif-
ferent concentrations of each inhibitor ranging from 0
nM to 10 mM were incubated with the assay mixtures
for 20 min at room temperature. The quenched reaction
mixtures were analyzed and absolute choline formation
was derived from the choline calibration curve. IC50s of
eserine, malathion, and edrophonium were calculated
to be 63  13 nM, 480  70 M, 63  11 M,
respectively. Neostigmine resulted in two IC50 values,
50  25 M and 38  10 nM, based on two-site
competition fitting. These numbers generally agreed
well with previously reported values (eserine 72–109
nM [34], malathion 370 M [35], edrophonium 5.4 M
[36], and neostigmine 11.3 nM [37]; however, direct
comparison of these numbers might not be appropriate
because the experimental conditions were not identical
(e.g., use of surrogate substrates and different AchE in
other assays).
Conclusions
We demonstrated that AchE inhibitors could be ana-
lyzed at throughput of 1.5 s/sample by preparing
samples as an array of individual nanoliter plugs seg-
mented by air and rapidly analyzing them using
ESI-MS serially. The throughput of analysis compares
favorably with flow injection methods. Further im-
provements in throughput are possible by using smaller
sample plugs and higher flow rates. Another advantage
of segmented flow analysis relative to flow injection
approaches is the low sample volume requirement.
rror
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because there is no need to fill and rinse an injection
loop. Of course, the total sample used depends on the
volume required to collect the 10 nL sample. In princi-
ple, it should be possible to aspirate sample from much
lower volume wells than used here.
Although the rate of analysis and sample utilization
demonstrated here are compatible with HTS, develop-
ing a true HTS system around this approach requires
further development. Overall throughput was limited
by sample loading in this case; therefore implementa-
tion of more rapid or parallel sample loading proce-
dures is necessary. Extending the approach to assays
that are not compatible with direct ESI injection will
require developing and applying methods of high-
throughput sample preparation.
Acknowledgments
The authors acknowledge support for this work by NSF-CHE
0514638. The ESI source and emitter tips were generously donated
by New Objective.
References
1. Gomez-Hens, A.; Aguilar-Caballos, M. P. Modern Analytical Ap-
proaches to High-Throughput Drug Discovery. Trac-Trends Anal. Chem.
2007, 26, 171–182.
Figure 5. Dose-response curves of four AchE
various inhibitor concentrations were fit to sigm
which was fit to a two-site competition curve. E2. Hodder, P.; Mull, R.; Cassaday, J.; Berry, K.; Strulovici, B. Miniaturiza-
tion of Intracellular Calcium Functional Assays to 1536-Well PlateFormat Using a Fluorometric Imaging Plate Reader. J. Biomol. Screen.
2004, 9, 417–426.
3. Miraglia, S.; Swartzman, E. E.; Mellentin-Michelotti, J.; Evangelista, L.;
Smith, C.; Gunawan, I.; Lohman, K.; Goldberg, E. M.; Manian, B.; Yuan,
P. M. Homogeneous Cell- and Bead-Based Assays for High Throughput
Screening Using Fluorometric Microvolume Assay Technology. J. Bi-
omol. Screen. 1999, 4, 193–204.
4. Hodgson, L. New Approaches to In-Cell Detection of Protein Activity:
Genetically Encoded Chemiluminescence Probes Pave the Way to
Robust HTS Assays. ACS Chem. Biol. 2008, 3, 335–337.
5. Liesener, A.; Karst, U. Monitoring Enzymatic Conversions by Mass
Spectrometry: A Critical Review. Anal. Bioanal. Chem. 2005, 382, 1451–
1464.
6. Zehender, H.; Mayr, L. M. Application of Mass Spectrometry Technol-
ogies for the Discovery of Low-Molecular Weight Modulators of
Enzymes and Protein–Protein Interactions. Curr. Opin. Chem. Biol. 2007,
11, 511–517.
7. Hofstadler, S. A.; Sannes-Lowery, K. A. Applications of ESI-MS in Drug
Discovery: Interrogation of Noncovalent Complexes. Nat. Rev. Drug
Discov. 2006, 5, 585–595.
8. Mathur, S.; Hassel, M.; Steiner, F.; Hollemeyer, K.; Hartmann, R. W.
Development of a New Approach for Screening Combinatorial Librar-
ies Using MALDI-TOF-MS and HPLC-ESI-MS/MS. J. Biomol. Screen.
2003, 8, 136–148.
9. Gao, J. M.; Cheng, X. H.; Chen, R. D.; Sigal, G. B.; Bruce, J. E.; Schwartz,
B. L.; Hofstadler, S. A.; Anderson, G. A.; Smith, R. D.; Whitesides, G. M.
Screening Derivatized Peptide Libraries for Tight Binding Inhibitors to
Carbonic Anhydrase II by Electrospray Ionization Mass Spectrometry.
J. Med. Chem. 1996, 39, 1949–1955.
10. Shiau, A. K.; Massari, M. E.; Ozbal, C. C. Back to Basics: Label-Free
Technologies for Small Molecule Screening. Comb. Chem. High Through-
put Screen. 2008, 11, 231–237.
11. Van Pelt, C. K.; Zhang, S.; Fung, E.; Chu, I. H.; Liu, T. T.; Li, C.;
Korfmacher, W. A.; Henion, J. A Fully Automated Nanoelectrospray
Tandem Mass Spectrometric Method for Analysis of Caco-2 Samples.
Rapid Commun. Mass Spectrom. 2003, 17, 1573–1578.
12. Furman, W. B. Continuous-Flow Analysis. Theory and Practice; CRC press:
New York, 1976.
13. Snyder, L. R. Continuous-Flow Analysis—Present and Future. Anal.
Chim. Acta 1980, 114, 3–18.
ibitors. Choline formed when incubated with
l dose-response curves except for neostigmine,
bars are 1 SD (n  3).inh
oida14. Song, H.; Chen, D. L.; Ismagilov, R. F. Reactions in Droplets in
Microfluidic Channels. Angew. Chem. Int. Ed. 2006, 45, 7336–7356.
1113J Am Soc Mass Spectrom 2010, 21, 1107–1113 HIGH-THROUGHPUT SCREENING BY ESI-MS15. Sgro, A. E.; Allen, P. B.; Chiu, D. T. Thermoelectric Manipulation of
Aqueous Droplets in Microfluidic Devices. Anal. Chem. 2007, 79, 4845–
4851.
16. Fidalgo, L. M.; Abell, C.; Huck, W. T. S. Surface-Induced Droplet Fusion
in Microfluidic Devices. Lab. Chip 2007, 7, 984–986.
17. Pei, J.; Li, Q.; Lee, M. S.; Valaskovic, G. A.; Kennedy, R. T. Analysis of
Samples Stored as Individual Plugs in a Capillary by Electrospray
Ionization Mass Spectrometry. Anal. Chem. 2009, 81, 6558–6561.
18. Fidalgo, L. M.; Whyte, G.; Ruotolo, B. T.; Benesch, J. L. P.; Stengel, F.;
Abell, C.; Robinson, C. V.; Huck, W. T. S. Coupling Microdroplet
Microreactors with Mass Spectrometry: Reading the Contents of Single
Droplets Online. Angew. Chem. Int. Ed. 2009, 48, 3665–3668.
19. Kelly, R. T.; Page, J. S.; Marginean, I.; Tang, K. Q.; Smith, R. D.
Dilution-Free Analysis from Picoliter Droplets by Nano-Electrospray
Ionization Mass Spectrometry. Angew. Chem. Int. Ed. 2009, 48, 6832–
6835.
20. Perry, E. Acetylcholine and Alzheimer’s Disease. Br. J. Psychiat. 1988,
152, 737–740.
21. Greenblatt, H. M.; Dvir, H.; Silman, I.; Sussman, J. L. Acetylcholinesterase—a
Multifaceted Target for Structure-Based Drug Design of Anticholines-
terase Agents for the Treatment of Alzheimer’s Disease. J. Mol. Neurosci.
2003, 20, 369–383.
22. Maidment, I.; Fox, C.; Livingston, G.; Katona, C. Drug Treatment for
Alzheimer’s Disease: The Way Forward. Int. J. Geriatr. Psychiat. 2006, 21,
6–8.
23. Ellman, G. L.; Courtney, K. D.; Andres, V.; Featherstone, R. M. A New
and Rapid Colorimetric Determination of Acetylcholinesterase Activity.
Biochem. Pharmacol. 1961, 7, 88–96.
24. Rhee, I. K.; Appels, N.; Luijendijk, T.; Irth, H.; Verpoorte, R. Determin-
ing Acetylcholinesterase Inhibitory Activity in Plant Extracts Using a
Fluorimetric Flow Assay. Phytochem. Anal. 2003, 14, 145–149.
25. Guardigli, M.; Pasini, P.; Mirasoli, M.; Leoni, A.; Andreani, A.; Roda, A.
Chemiluminescent High-Throughput Microassay for Evaluation of Ace-
tylcholinesterase Inhibitors. Anal. Chim. Acta 2005, 535, 139–144.
26. Ingkaninan, K.; de Best, C. M.; van der Heijden, R.; Hofte, A. J. P.;
Karabatak, B.; Irth, H.; Tjaden, U. R.; van der Greef, J.; Verpoorte, R.
High-Performance Liquid Chromatography with on-Line Coupled UV,
Mass Spectrometric and Biochemical Detection for Identification of
Acetylcholinesterase Inhibitors from Natural Products. J. Chromatogr. A
2000, 872, 61–73.27. Ozbal, C. C.; LaMarr, W. A.; Linton, J. R.; Green, D. F.; Katz, A.;
Morrison, T. B.; Brenan, C. J. H. High Throughput Screening Via Mass
Spectrometry: A Case Study Using Acetylcholinesterase. Assay Drug
Dev. Technol. 2004, 2, 373–381.
28. Hu, F. L.; Zhang, H. Y.; Lin, H. Q.; Deng, C. H.; Zhang, X. M. Enzyme
Inhibitor Screening by Electrospray Mass Spectrometry with Immobi-
lized Enzyme on Magnetic Silica Microspheres. J. Am. Soc. Mass
Spectrom. 2008, 19, 865–873.
29. Andrisano, V.; Bartolini, M.; Gotti, R.; Cavrini, V.; Felix, G. Determina-
tion of Inhibitors’ Potency (IC50) by a Direct High-Performance Liquid
Chromatographic Method on an Immobilized Acetylcholinesterase Col-
umn. J. Chromatogr. B 2001, 753, 375–383.
30. Link, D. R.; Anna, S. L.; Weitz, D. A.; Stone, H. A. Geometrically
Mediated Breakup of Drops in Microfluidic Devices. Phys. Rev. Lett.
2004, 92, 054503.
31. Chabert, M.; Dorfman, K. D.; de Cremoux, P.; Roeraade, J.; Viovy, J. L.
Automated Microdroplet Platform for Sample Manipulation and Poly-
merase Chain Reaction. Anal. Chem. 2006, 78, 7722–7728.
32. Vuckovic, D.; Cudjoe, E.; Hein, D.; Pawliszyn, J. Automation of Solid-
Phase Microextraction in High-Throughput Format and Applications to
Drug Analysis. Anal. Chem. 2008, 80, 6870–6880.
33. Zhang, J. H.; Chung, T. D. Y.; Oldenburg, K. R. A Simple Statistical
Parameter for Use in Evaluation and Validation of High Throughput
Screening Assays. J. Biomol. Screen. 1999, 4, 67–73.
34. Vinutha, B.; Prashanth, D.; Salma, K.; Sreeja, S. L.; Pratiti, D.; Padmaja,
R.; Radhika, S.; Amit, A.; Venkateshwarlu, K.; Deepak, M. Screening of
Selected Indian Medicinal Plants for Acetylcholinesterase Inhibitory
Activity. J. Ethnopharmacol. 2007, 109, 359–363.
35. Krstic, D. Z.; Colovic, M.; Kralj, M. B.; Franko, M.; Krinulovic, K.;
Trebse, P.; Vasic, V. Inhibition of AchE by Malathion and Some
Structurally Similar Compounds. J. Enzyme Inhib. Med. Chem. 2008, 23,
562–573.
36. Alvarez, A.; Alarcon, R.; Opazo, C.; Campos, E. O.; Munoz, F. J.;
Calderon, F. H.; Dajas, F.; Gentry, M. K.; Doctor, B. P.; De Mello, F. G.;
Inestrosa, N. C. Stable Complexes Involving Acetylcholinesterase and
Amyloid- Peptide Change the Biochemical Properties of the Enzyme
and Increase the Neurotoxicity of Alzheimer’s Fibrils. J. Neurosci. 1998,
18, 3213–3223.
37. Iwanaga, Y.; Kimura, T.; Miyashita, N.; Morikawa, K.; Nagata, O.; Itoh,
Z.; Kondo, Y. Characterization of Acetylcholinesterase Inhibition by
Itopride. Jpn. J. Pharmacol. 1994, 66, 317–322.
